GH1 and neoplasm: Younger male patients generally exhibit poorer responses to SRLs (101), while factors such as lower GH levels at diagnosis, smaller tumor size, and the absence of cavernous sinus invasion are closely linked to better hormonal responses to SRL treatment (56).